The American healthcare system is at a tipping point. With increasing government coverage, rising chronic disease prevalence, and narrowing innovation, the need for reform has never been more critical. Change agents in the new administration are poised to usher in sweeping policy changes, which will re-shape the commercial calculus for Pharma, Payers, and Providers.

Our latest analysis explores the forces shaping Healthcare’s new frontier and the impact it will have across:  

• Drug approvals
• Reimbursement Models
• Patient Safety
• M&A

Understanding these dynamics is essential for healthcare leaders looking to build resilience amidst uncertainty and position their organizations for success under the new administration.

Download the Report